Edwards Lifesciences Corp’s recently made public that its CVP, JAPAC Lippis Daniel J. unloaded Company’s shares for reported $24560.0 on May 09 ’25. In the deal valued at $74.42 per share,330 shares were sold. As a result of this transaction, Lippis Daniel J. now holds 26,616 shares worth roughly $1.96 million.
Then, Markowitz Wayne sold 268 shares, generating $20,121 in total proceeds. Upon selling the shares at $75.08, the GM & SVP, Surgical now owns 9,299 shares.
Before that, Ullem Scott B. sold 11,250 shares. Edwards Lifesciences Corp shares valued at $837,035 were divested by the CVP, Chief Financial Officer at a price of $74.40 per share. As a result of the transaction, Ullem Scott B. now holds 41,098 shares, worth roughly $3.03 million.
Piper Sandler upgraded its Edwards Lifesciences Corp [EW] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who increased its forecast for the stock in late January from “a Hold” to “a Buy”. Wolfe Research also remained covering EW and has decreased its forecast on January 16, 2025 with a “an Underperform” recommendation from previously “Peer perform” rating. BofA Securities revised its rating on December 16, 2024. It rated EW as “a Buy” which previously was an “a Neutral”.
Price Performance Review of EW
On Friday, Edwards Lifesciences Corp [NYSE:EW] saw its stock fall -1.27% to $73.68. Over the last five days, the stock has lost -2.60%. Edwards Lifesciences Corp shares have fallen nearly -0.47% since the year began. Nevertheless, the stocks have fallen -14.17% over the past one year. While a 52-week high of $95.25 was reached on 05/02/25, a 52-week low of $58.93 was recorded on 04/09/25. SMA at 50 days reached $71.60, while 200 days put it at $70.05.
Levels Of Support And Resistance For EW Stock
The 24-hour chart illustrates a support level at 73.22, which if violated will result in even more drops to 72.77. On the upside, there is a resistance level at 74.52. A further resistance level may holdings at 75.37. The Relative Strength Index (RSI) on the 14-day chart is 52.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.10, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.49%. Stochastics %K at 67.56% indicates the stock is a holding.
